Genome-wide screen identifies a novel prognostic signature for breast cancer survival

Large genomic datasets in combination with clinical data can be used as an unbiased tool to identify genes important in patient survival and discover potential therapeutic targets. We used a genome-wide screen to identify 587 genes significantly and robustly deregulated across four independent breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Xuan Y, Lee, Matthew J, Zhu, Jeffrey, Zhu, Carissa, Law, Sindy M, Snijders, Antoine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355157/
https://www.ncbi.nlm.nih.gov/pubmed/28122328
http://dx.doi.org/10.18632/oncotarget.14776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355157/
https://www.ncbi.nlm.nih.gov/pubmed/28122328
http://dx.doi.org/10.18632/oncotarget.14776

Ejemplares similares